Cancer immunoediting and resistance to T cell-based immunotherapy.
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167. doi: 10.1038/s41571-018-0142-8.
Nat Rev Clin Oncol. 2019.
PMID: 30523282
Review.